Facile fabrication of antibacterial and antiviral perhydrolase-polydopamine composite coatings.

Anti-Bacterial Agents / chemistry Antiviral Agents / chemistry Bacterial Proteins / chemistry COVID-19 / pathology Coated Materials, Biocompatible / chemistry Drug Stability Gram-Negative Bacteria / drug effects Gram-Positive Bacteria / drug effects Humans Hydrolases / chemistry Indoles / chemistry Kinetics Mycobacterium smegmatis / enzymology Peracetic Acid / metabolism Polymers / chemistry Recombinant Proteins / biosynthesis SARS-CoV-2 / drug effects

Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
14 06 2021
Historique:
received: 22 02 2021
accepted: 31 05 2021
entrez: 15 6 2021
pubmed: 16 6 2021
medline: 25 6 2021
Statut: epublish

Résumé

In situ generation of antibacterial and antiviral agents by harnessing the catalytic activity of enzymes on surfaces provides an effective eco-friendly approach for disinfection. The perhydrolase (AcT) from Mycobacterium smegmatis catalyzes the perhydrolysis of acetate esters to generate the potent disinfectant, peracetic acid (PAA). In the presence of AcT and its two substrates, propylene glycol diacetate and H

Identifiants

DOI: 10.1038/s41598-021-91925-6 PMID: 34127732 PMC: PMC8203652
pubmed: 34127732
doi: 10.1038/s41598-021-91925-6
pii: 10.1038/s41598-021-91925-6
pmc: PMC8203652
doi:

Substances chimiques

Anti-Bacterial Agents 0
Antiviral Agents 0
Bacterial Proteins 0
Coated Materials, Biocompatible 0
Indoles 0
Polymers 0
Recombinant Proteins 0
polydopamine 0
Hydrolases EC 3.-
Peracetic Acid I6KPI2E1HD

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12410

Subventions

Organisme : National Research Foundation of Korea
ID : 2014K1A1A2043032

Références

Infect Control Hosp Epidemiol. 2021 Mar;42(3):274-279
pubmed: 32993827
PDA J Pharm Sci Technol. 2010 Sep-Oct;64(5):481-5
pubmed: 21502056
J Colloid Interface Sci. 2016 Sep 1;477:123-30
pubmed: 27254254
Tissue Eng Part C Methods. 2013 Aug;19(8):610-9
pubmed: 23231507
Appl Environ Microbiol. 1996 Feb;62(2):545-51
pubmed: 8593054
Langmuir. 2012 Apr 3;28(13):5775-82
pubmed: 22397599
Science. 2007 Oct 19;318(5849):426-30
pubmed: 17947576
Biochemistry. 2007 Aug 7;46(31):8969-79
pubmed: 17636869
Angew Chem Int Ed Engl. 2005 Apr 29;44(18):2742-6
pubmed: 15803517
Science. 2020 Oct 23;370(6515):406-407
pubmed: 33093098
Mol Ther Methods Clin Dev. 2021 Mar 12;20:350-356
pubmed: 33521163
Parasitol Res. 2013 Oct;112(10):3669-78
pubmed: 23955563
Int J Environ Health Res. 2015;25(2):115-25
pubmed: 24725246
Rev Med Virol. 2018 Jan;28(1):
pubmed: 29218769
J Virol. 2021 Jan 13;95(3):
pubmed: 33173010
J Food Prot. 1999 Jul;62(7):761-5
pubmed: 10419269
Lancet Infect Dis. 2013 Dec;13(12):1057-98
pubmed: 24252483
Langmuir. 2016 Nov 22;32(46):12119-12128
pubmed: 27933877
PLoS One. 2014 Mar 03;9(3):e89924
pubmed: 24594755
Toxicol Ind Health. 1987 Dec;3(4):535-68
pubmed: 3324392
Nat Med. 2020 Apr;26(4):450-452
pubmed: 32284615
J Biotechnol. 2014 Oct 20;188:36-41
pubmed: 25093935
J Mater Chem B. 2015 May 28;3(20):4181-4190
pubmed: 32262295
Langmuir. 2018 Feb 27;34(8):2585-2594
pubmed: 29381365
J Food Prot. 2019 May;82(5):889-902
pubmed: 31021666
Appl Microbiol Biotechnol. 2013 Oct;97(19):8813-21
pubmed: 23188457
Antiviral Res. 2002 May;54(2):89-97
pubmed: 12062394
Appl Microbiol Biotechnol. 2013 Apr;97(8):3293-300
pubmed: 23474614
Materials (Basel). 2020 Sep 11;13(18):
pubmed: 32933043
Langmuir. 2019 Feb 5;35(5):1642-1651
pubmed: 30114915
MMWR Morb Mortal Wkly Rep. 2016 Apr 15;65(14):368-71
pubmed: 27077946
Front Immunol. 2020 Oct 07;11:576622
pubmed: 33117378
Environ Int. 2004 Mar;30(1):47-55
pubmed: 14664864
Int J Mol Sci. 2018 Sep 21;19(10):
pubmed: 30248951
Nat Rev Microbiol. 2021 Mar;19(3):141-154
pubmed: 33024307
Langmuir. 2015 Jan 27;31(3):1064-73
pubmed: 25547537
J Biotechnol. 2006 Nov 1;126(2):140-51
pubmed: 16730828
Science. 1999 May 21;284(5418):1318-22
pubmed: 10334980
ACS Appl Mater Interfaces. 2018 Mar 7;10(9):7523-7540
pubmed: 29465221
Am J Infect Control. 2010 Jun;38(5 Suppl 1):S25-33
pubmed: 20569853
Biosurf Biotribol. 2016 Dec;2(4):121-136
pubmed: 29888337

Auteurs

Li-Sheng Wang (LS)

Department of Chemical and Biological Engineering and Center for Biotechnology & Interdisciplinary Studies, Rensselaer Polytechnic Institute, 110 8th Street, Troy, 12180, USA.

Shirley Xu (S)

Department of Chemical and Biological Engineering and Center for Biotechnology & Interdisciplinary Studies, Rensselaer Polytechnic Institute, 110 8th Street, Troy, 12180, USA.

Sneha Gopal (S)

Department of Chemical and Biological Engineering and Center for Biotechnology & Interdisciplinary Studies, Rensselaer Polytechnic Institute, 110 8th Street, Troy, 12180, USA.

Eunsol Kim (E)

Department of Chemical and Biological Engineering and Center for Biotechnology & Interdisciplinary Studies, Rensselaer Polytechnic Institute, 110 8th Street, Troy, 12180, USA.

Domyoung Kim (D)

Department of Chemical and Biological Engineering and Center for Biotechnology & Interdisciplinary Studies, Rensselaer Polytechnic Institute, 110 8th Street, Troy, 12180, USA.

Matthew Brier (M)

Department of Chemical and Biological Engineering and Center for Biotechnology & Interdisciplinary Studies, Rensselaer Polytechnic Institute, 110 8th Street, Troy, 12180, USA.

Kusum Solanki (K)

Department of Chemical and Biological Engineering and Center for Biotechnology & Interdisciplinary Studies, Rensselaer Polytechnic Institute, 110 8th Street, Troy, 12180, USA.

Jonathan S Dordick (JS)

Department of Chemical and Biological Engineering and Center for Biotechnology & Interdisciplinary Studies, Rensselaer Polytechnic Institute, 110 8th Street, Troy, 12180, USA. dordick@rpi.edu.
Department of Biological Sciences, Rensselaer Polytechnic Institute, 110 8th Street, Troy, NY, 12180, USA. dordick@rpi.edu.
Department of Biomedical Engineering, Rensselaer Polytechnic Institute, 110 8th Street, Troy, NY, 12180, USA. dordick@rpi.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Facile fabrication of antibacterial and...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antiviraux › Facile fabrication of antibacterial and...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines bactériennes › Facile fabrication of antibacterial and...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › Facile fabrication of antibacterial and...
questionsmedicales.fr › Technologie, industrie et agriculture › Produits manufacturés › Matériaux biomédicaux et dentaires › Matériaux biocompatibles › Matériaux revêtus, biocompatibles › Facile fabrication of antibacterial and...
questionsmedicales.fr › Techniques d'investigation › Stabilité de médicament › Facile fabrication of antibacterial and...
questionsmedicales.fr › Bactéries › Bactéries à Gram négatif › Facile fabrication of antibacterial and...
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Facile fabrication of antibacterial and...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Facile fabrication of antibacterial and...
questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Hydrolases › Facile fabrication of antibacterial and...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › Indoles › Facile fabrication of antibacterial and...
questionsmedicales.fr › Phénomènes chimiques › Phénomènes biochimiques › Cinétique › Facile fabrication of antibacterial and...
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Bâtonnets à Gram positif › Bâtonnets asporogènes à Gram positif › Bâtonnets asporogènes réguliers à Gram positif › Mycobacteriaceae › Mycobacterium › Mycobactéries non tuberculeuses › Mycobacterium smegmatis › Facile fabrication of antibacterial and...
questionsmedicales.fr › Composés chimiques organiques › Acides carboxyliques › Acides acycliques › Acide peracétique › Facile fabrication of antibacterial and...
questionsmedicales.fr › Technologie, industrie et agriculture › Produits manufacturés › Matériaux biomédicaux et dentaires › Polymères › Facile fabrication of antibacterial and...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines recombinantes › Facile fabrication of antibacterial and...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Virus du SRAS › SARS-CoV-2 › Facile fabrication of antibacterial and...